Literature DB >> 31661719

Feature selection for OPLS discriminant analysis of cancer tissue lipidomics data.

Alisa O Tokareva1,2, Vitaliy V Chagovets3, Natalia L Starodubtseva3, Niso M Nazarova3, Maria E Nekrasova3, Alexey S Kononikhin1,4, Vladimir E Frankevich3, Evgeny N Nikolaev2,4, Gennady T Sukhikh3.   

Abstract

The mass spectrometry-based molecular profiling can be used for better differentiation between normal and cancer tissues and for the detection of neoplastic transformation, which is of great importance for diagnostics of a pathology, prognosis of its evolution trend, and development of a treatment strategy. The aim of the present study is the evaluation of tissue classification approaches based on various data sets derived from the molecular profile of the organic solvent extracts of a tissue. A set of possibilities are considered for the orthogonal projections to latent structures discriminant analysis: all mass spectrometric peaks over 300 counts threshold, subset of peaks selected by ranking with support vector machine algorithm, peaks selected by random forest algorithm, peaks with the statistically significant difference of the intensity determined by the Mann-Whitney U test, peaks identified as lipids, and both identified and significantly different peaks. The best predictive potential is obtained for OPLS-DA model built on nonpolar glycerolipids (Q2 = 0.64, area under curve [AUC] = 0.95); the second one is OPLS-DA model with lipid peaks selected by random forest algorithm (Q2 = 0.58, AUC = 0.87). Moreover, models based on particular molecular classes are more preferable from biological point of view, resulting in new explanatory mechanisms of pathophysiology and providing a pathway analysis. Another promising features for OPLS-DA modeling are phosphatidylethanolamines (Q2 = 0.48, AUC = 0.86).
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ESI-MS; cervical cancer; discriminant model; feature selection; mass spectrometry; shotgun lipidomics

Mesh:

Substances:

Year:  2019        PMID: 31661719     DOI: 10.1002/jms.4457

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  5 in total

1.  Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation.

Authors:  Natalia L Starodubtseva; Vitaliy V Chagovets; Maria E Nekrasova; Niso M Nazarova; Alisa O Tokareva; Olga V Bourmenskaya; Djamilja I Attoeva; Eugenii N Kukaev; Dmitriy Y Trofimov; Vladimir E Frankevich; Gennady T Sukhikh
Journal:  Metabolites       Date:  2022-05-31

2.  Validation of Breast Cancer Margins by Tissue Spray Mass Spectrometry.

Authors:  Vitaliy V Chagovets; Natalia L Starodubtseva; Alisa O Tokareva; Vladimir E Frankevich; Valerii V Rodionov; Vlada V Kometova; Konstantin Chingin; Eugene N Kukaev; Huanwen Chen; Gennady T Sukhikh
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

3.  Identification of novel neuroblastoma biomarkers in urine samples.

Authors:  Kazuki Yokota; Hiroo Uchida; Minoru Sakairi; Mayumi Abe; Yujiro Tanaka; Takahisa Tainaka; Chiyoe Shirota; Wataru Sumida; Kazuo Oshima; Satoshi Makita; Hizuru Amano; Akinari Hinoki
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 4.  Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review.

Authors:  Janina Tokarz; Jerzy Adamski; Tea Lanišnik Rižner
Journal:  J Pers Med       Date:  2020-12-21

5.  Alterations in lipid profile upon uterine fibroids and its recurrence.

Authors:  Narine M Tonoyan; Vitaliy V Chagovets; Natalia L Starodubtseva; Alisa O Tokareva; Konstantin Chingin; Irena F Kozachenko; Leyla V Adamyan; Vladimir E Frankevich
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.